Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says
The CEO of Gilead Sciences says U.S. hospitals should get enough of its drug to fight COVID-19 to treat as many as 200,000 patients this week.
Coronavirus treatment drug remdesivir to arrive in hospitals this week, Gilead CEO says
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Administration initially dispensed scarce COVID-19 drug to some hospitals that didn’t need it
Seattle Times
The Trump administration mishandled the initial distribution of the only approved coronavirus medication, delaying treatment to..
-
CytoDyn co-ordinates with Mexican Institutes of Health on leronlimab trial for severe coronavirus patients
Proactive Investors
-
Oregon hospitals to receive experimental Covid treatment
bizjournals
-
CytoDyn unveils further clinical trial plans in bid to fight coronavirus pandemic
Proactive Investors
-
NA Proactive news snapshot: Pacific Empire Minerals, American Manganese, NexTech AR, Co-Diagnostics, Dyadic International UPDATE ...
Proactive Investors
Advertisement
More coverage
Hospitals left waiting, the sharing economy gets sliced, and the future of shopping
Business Insider
Hello!
A little over a week ago, on May 1, a promising coronavirus treatment called remdesivir was quickly approved for..
